title: Lethal multiple sclerosis relapse after natalizumab withdrawal.
authors.affiliation: Service d'Anatomopathologie, CHRU de Montpellier, Université Montpellier I, Montpellier, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Rigau
authors.forename: Alexandre
authors.initials: A
authors.lastname: Mania
authors.forename: Patrice
authors.initials: P
authors.lastname: Béfort
authors.forename: Bertrand
authors.initials: B
authors.lastname: Carlander
authors.forename: Olivier
authors.initials: O
authors.lastname: Jonquet
authors.forename: Hans
authors.initials: H
authors.lastname: Lassmann
authors.forename: William
authors.initials: W
authors.lastname: Camu
authors.forename: Eric
authors.initials: E
authors.lastname: Thouvenot
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000379:methods; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D000069442:Natalizumab; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000276:immunology / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab